Resources

Browse manuscripts, abstracts, posters, and presentations related to our neurology program.
Journal articles may open on publisher websites and can require subscription access.
Showing 16 resources
Poster
Presented at MDS
2026

Continued Evaluation of Clinical Outcomes in Participants With Parkinson’s Disease Through 4 Years After Bemdaneprocel Administration

Claire Henchcliffe, MD, DPhil; Harini Sarva, MD; Alfonso Fasano, MD, PhD; Andres Lozano, MD, PhD; Suneil Kalia, MD, PhD, FAANS, FRCSC; Kenny Kwok Hei Yu, MBBS, PhD, FRCS; Cameron Brennan, MD; Jie Liu, MS; Jigar Patel, BPharm; Gabi Belfort, MD, PhD; Viviane Tabar, MD
View More Download PDF
Medical Education
Online
2026

AD/PD™ Research Spotlight: Phase I trial of hES cell-derived dopaminergic neurons for PD

View More Visit Resource
Medical Education
Online
2026

Stem Cell Medicine: From Scientific Research to Patient Care

View More Visit Resource
Medical Education
ANN
2026

Let’s Get Social About Cell- and Gene-Based Therapies in Parkinson Disease

View More Visit Resource
Medical Education
Online
2026

Stem Cell Medicine: Parkinson’s Disease

View More Visit Resource
Medical Education
Presented at MDS
2026

Reimagining Parkinson Care: The Potential of Novel Therapies and Regenerative Medicine

Joohi Jimenez-Shahed, MD; Daniel Kremens, MD, JD, FAAN; William G. Ondo, MD
View More Visit Resource
Manuscript
Published in Nature
2025

Phase I trial of hES cell-derived dopaminergic neurons for Parkinson’s disease

Viviane Tabar, MD; Harini Sarva, MD; Andres Lozano, MD; Alfonso Fasano, MD, PhD; Suneil Kalia, MD, PhD, FAANS, FRCSC; Kenny Kwok Hei Yu, MBBS, PhD, FRCS; Cameron Brennan, MD; Yilong Ma, PhD; Shichun Peng, PhD; David Eidelberg, MD; Mark Tomishima, PhD; Stefan Irion, MD; Whitney Stemple; MS; Nauman Abid, MD; Antoine Lampron, PhD; Lorenz Studer, MD; Claire Henchcliffe, MD, DPhil
View More Visit Resource
Poster
Presented at MDS
2025

Continued Evaluation of Bemdaneprocel Following a Phase 1 Study for Parkinson’s Disease: Outcomes Through 3 Years

Harini Sarva, MD; Claire Henchcliffe, MD, DPhil; Andres Lozano, MD, PhD; Alfonso Fasano, MD, PhD; Suneil Kalia, MD, PhD, FAANS, FRCSC; Kenny Kwok Hei Yu, MBBS, PhD, FRCS; Cameron Brennan, MD; Melinda Louie-Gao, PhD; Nicole Floro, MS; Nauman Abid, MD; Viviane Tabar, MD
View More Download PDF
Poster
Presented at PSG
2025

exPDite-2: A Phase 3, Randomized, Sham-Controlled, Double-Blind Trial to Evaluate Bemdaneprocel, a Midbrain Dopaminergic Neuron Progenitor Cell Therapy for Parkinson’s Disease

Nauman Abid, MD; Mathews Adera, MD; Melinda Louie-Gao, PhD; Gabriel Belfort, MD, PhD
View More Download PDF
Poster
Presented at MDS
2025

Continued Evaluation of Safety, Motor, and Non-Motor Outcomes in Participants With Parkinson’s Disease Through 3 Years After Bemdaneprocel Administration

Alfonso Fasano, MD, PhD; Harini Sarva, MD; Claire Henchcliffe, MD, DPhil; Andres Lozano, MD, PhD; Suneil Kalia, MD, PhD, FAANS, FRCSC; Kenny Kwok Hei Yu, MBBS, PhD, FRCS; Cameron Brennan, MD; Melinda Louie-Gao, PhD; Nicole Floro, MS; Nauman Abid, MD; Viviane Tabar, MD
View More Download PDF
Showing 1 - 10 of 16